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Summary.-The level of peripheral blood platelets was determined after i.v. injec-
tion of Corynebacterium parvum in normal C57BL mice and in those bearing the Lewis
lung carcinoma.
Twentyminutes after injection of aformalin-killed active strain (CN6134, whichin-
hibited tumour metastases) or a killed inactive strain (CN5888, which did not inhibit
metastases) the number of circulating blood platelets was reduced by 50.0o The level
of platelets returned to control values by 8 h after the active, and by 3 days after
the inactive strain. The active strain alone caused a second and prolonged fall in
platelet numbers, from 16 h to 21 days after injection. Heparin given 3 x weekly
to these mice restored the platelet count to normal values by 10 days after injection
of active-strain C. parvum. The level of platelets in tumour-bearing mice was essen-
tially similar to that in normal mice.
Possible causes of the thrombocytopenia and the significance of platelets in meta-
stasis are discussed.
IN THIS investigation, 2 strains of
formalin-killed C. parvum were used: an
active strain (CN 6134) which causes
hepatosplenomegaly and inhibits tumour
growth, and an inactive one (CN 5888)
which does not have these effects (Adlam
and Scott, 1973; Bomford and Olivotto,
1975).
In rodents, systemic administration of
active C. parrurn inhibits the development
of tumour nodules in the lungs, arising
either from i.v. injection of tumour cells
(Milas and Mujagic, 1972; Bomford and
Olivotto, 1974) or as spontaneous meta-
stases from a tumour implant (Proctor,
Rudenstam and Alexander, 1973: Sadler
and Castro, 1976). The protection afforded
by this vaccine has generally been attri-
buted to its stimulatory effect on the
reticulo-endothelial system (Halpern et al.,
1966: Scott, 1974).
Recently we reported another effect
of C. parrurn which may influence
metastasis (Lampert et al., 1977): a
prolonged intravascular coagulation reac-
tion occurs after i.v. C. parvum, resulting
in thrombi in hepatic, splenic and pul-
monary vessels. This thrombosis is mir-
rored by a fall in platelet counts. Pre-
liminary investigations (Mitcheson and
Castro, unpublished) suggest that a similar
phenomenon occurs in man. A decrease in
platelets and an increase in fibrin degrada-
tion products have been observed in
patients given i.v. C. parvum. We now
wish to report the effects of systemic
C. parvrum on platelet levels in normal
and tumour-bearing mice.
MATERIALS AND METHODS
Mice.-Age-matched, female C57BL/10
Sc Sn mice weighing 18-23 g, obtained from
Olac (Southern) Ltd were used in most of
the investigations. Male C57BL/10 Sc Sn
mice from Bantin and Kingman were used
for the studies with heparin.
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Tumour. The Lewis lung carcinoma was
implanted s.c. as a OIml homogenate in the
lowN-er flank. It originated spontaneously as
a carcinoma of the lung in a female C57BL
mouse at the Wistar Institute in 1951
(Sugiura and Stock, 1955). Macroscopic
surface lung metastases were counted 21
days aftertumourimplantation, after staining
the lungs by inflation with a dilute solution
of Indian ink and fixation in Fekete's
solution (Wexler, 1966). The numbers of
mnetastases in the different experimental
groups were compared by Student's t test.
C. pairvum. A formalin-killed suspension
of active strain (Wellcome, CN 6134, batch
BA 3935/A, 7 mg dry weight/ml) or inactive
strain (Wellcome, CN 5888/C, (CA 500), 7 mg
dry weight/ml) was injected i.v. at a dose of
0-466 mg in 0-2 mlnormal saline. Control mice
received an equivalent volume of saline.
Heparin. Heparin (Paines and Byrne
Ltd, Batch 633010 (Mucous) B.P., preserva-
tive free) was given as 100 u i.v. at the same
time as C. parvum and subsequently as 100 u
s.c. 3 x Neekly.
Platelet count. Groups of 4 mice were
given i.v. C. parvitum or saline, and blood was
sampled at intervals after injection. Bleeding
was induced from the retro-orbital plexus
using a heparinised capillary tube (Hawksley,
England) and a 0 02 ml sample of the ef-
fusing blood was immediately collected into
a heparinised w%ihite-backed micro-pipette.
The sample was diluted in 2 ml of 1%
ammonium oxalate in a plastic microcapped
tube and was mechanically shaken for 3 to 5
nin. A Neubauer counting chamber was
filled with the diluted sample and left for
15-20 min in a moist container in order to
allow the platelets to settle. Platelets were
then counted under phase, using a x 10
objective and the mean total count (± s.e.)
was estimated (Miale, 1962).
RESULTS
Within 10-20 min of injection of
active- or inactive-strain C. parvum, the
mice showed signs of shock, exemplified
by erection of hair, respiratory distress
and a "coldness to the touch". This
syndrome disappeared after about 2 h.
The long-term effect of active-strain
C. parvurn on platelet numbers in normal
mice is shown in Fig. 1. There was an
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initial fall in platelet levels at 20 min.
Subsequently, the platelets increased by
8 h to normal values. This was followed by
a second fall to 5000 of the control values
by 16 h. This decrease of platelets was
maintained until Day 17, when the level
increased, reaching normal values by Days
20-22.
An investigation was made of the effect
of heparin on platelet levels in normal
mice and in those treated with active-
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FIG. 4. Effects in normal female C57BL
mice of i.v. active strain of C. parvum
.-------.., or saline, , and in tumour.
bearing mice of C. parvum, or
saline -*---*, on platelet levels. Each
point represents the mean from 4 mice,
with bar denoting s.e.
strain C. parvum. Heparin was adminis-
tered i.v. at the same time as C. parvum
and then s.c. 3 x weekly for the duration
of the experiment. The results are shown
in Fig. 2. The count in control animals was
higher than in the previous experiment
(Fig. 1). However, the mice were of the
opposite sex and from a different supplier
than those used previously.) C. parvum
again caused a significant and prolonged
reduction of platelets. Heparin treatment
alone produced an increase in the platelet
count; subsequently this level fell to a
value similar to that in control mice. In
animals given C. parvum and heparin, the
number of platelets was reduced up to 7
days after the vaccine and was not
significantly different from that in mice
given C. parvum alone. However, by Day
10 the number of platelets had returned
to near control values, whilst the level of
platelets in mice treated with C. parvum
alone was still significantly reduced.
The action of inactive-strain C. parvum
was different from that of the active
strain. There was an immediate reduction
52
in platelets to 50% of normal and this
level was maintained for 24 h. Subse-
quently, the platelet count returned
towards normal, reaching control levels
by Days 3-5 (Fig. 3).
The effects of active-strain C. parvum
on platelet numbers in normal mice and in
those bearing the Lewis tumour were
compared (Fig. 4). Platelet levels in
tumour-bearing mice were similar to
those in normal animals until 13 days
after tumour inoculation. Subsequently,
the number of platelets fell in tumour
bearers to 60%, by Day 17, of that in
control mice. When C. parvum was given
at the same time as tumour inoculation,
the level of platelets in tumour-bearing
mice was reduced and essentially similar
to that in normal animals given vaccine.
A study was made of the effect ofthese
two vaccines on spontaneous pulmonary
metastases from the Lewis tumour. The
results are shown in the Table. Active-
strain C. parvum significantly reduced
metastases (P < 0.01) whereas inactive
strain had no significant effect.
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TABLE.-Effect of Active and Inactive
Strains of C. parvum on Metastases from
the Lewis Tumour
Metastases
Treatment t (Mean s.d(.)
Saline 36 16
Active C. PIarvunm 9 6*
Inactive C. pairvum 45 19
t 6 mice for each treatment
* Significant by Students t test < 0-01
DISCUSSION
By 20 min after i.v. inoculation of a
suspension of formalin-killed active- or
inactive-strain (CN 6134 or CN 5888)
C. parvum, C57BL mice showed signs of
shock, exemplified by respiratory distress,
erection of hair and coldness. At this
time, fibrin thrombi were present in the
lungs (Lampert et al., 1977) and the level
of circulating blood platelets was reduced.
A similar decrease in platelet numbers
occurs after i.v. inoculation of any
particulate matter (Tait and Elvidge,
1926). This is a reflection of platelets
aggregating with the injected antigen
(Brown andLachman, 1973). Antibodyand
complement may be involved in this
process (Henson, 1970).
The level ofplatelets returned to normal
by 8 h after injection of active-strain
C. parvum, whereas normal platelet values
were not regained until -, 3 days after the
inactive strain. Tait and Elvidge (1926)
reported that injections of large amounts
of particulate matter cause a greater
decrease in platelet levels and a slower
recovery to normal values than injections
of small amounts. On a weight basis,
similar quantities of the two vaccines
were injected and, therefore, our results
suggest that the inactive strain of C.
parvum causes a greater degree of platelet
aggregation than the active strain.
Only the active strain caused a second
and prolonged thrombocytopenia from
- 16 h to 21 days after its injection.
This thrombocytopenia was probably, to
some extent, due to pooling of platelets
in the spleen, which is enlarged after
active-strain C. parvum (Adlam and
Scott, 1973). Additionally, the reduction
in platelet numbers may be caused by the
intravascular coagulation which occurs
after i.v. injection ofthe active- (Lampert
et al., 1977) buit not the inactive-strain C.
parvrum (own unpublishedwork). A similar
reduction of platelets has been reported
during endotoxin-induced disseminated
intravascular coagulation (DIC) Brown
and Lachman, 1973; Beller, 1969). Heparin
is used clinically to treat DIC, and it has
been reported to prevent thrombosis and
to restore the level of platelets (Merskey
et al., 1964; Lasch, 1969). We therefore
investigated the effect of heparin on
platelet levels in C. parvum-treated mice.
Up to 7 days after injection of vaccine,
the number of platelets in mice given C.
parvum and heparin was decreased and
not significantly different from that in
animals given C. parvurn alone. This
suggests either that intravascular co-
agulation is not important in the thrombo-
cytopenia or that an inadequate dosage of
heparin was used (Good and Thomas,
1953). However, the platelet level at 10
days after injection was significantly
higher than that in mice treated with
C. parvum alone. This suggests that the
thrombocytopenia which occurs after
active-strain C. parvum is due, at least in
part, to intravascular coagulation. It
seems unlikely that C. parvum-induced
thrombocytopenia is due to impairment
of platelet production, as increased num-
bers of megakaryocytes are observed in
the spleens of mice after injection of the
active strain (Lampert et al., 1977).
The level of platelets in mice bearing
the Lewis tumour was similar to that in
control animals up to 13 days after
tumour inoculation. Subsequently, the
number ofplatelets was reduced in tumour
bearers. A similar effect has recently been
reported by Poggi et al. (1977) who
suggested that this phenomenon was due
to an impaired production of platelets.
Active-strain C. parvum caused a reduc-
tion in platelet levels in tumour-beariing
mice similar to that in control animals.
The active strain of C. parvum caused
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prolonged thrombocytopenia and also
significantly reduced metastases from the
Lewis tumour. The inactive strain showed
neither of these effects. This suggests that
the thrombocytopenia which occurs after
C. parvum may be a factor in the reduction
of pulmonary metastases. A pathogenic
role of blood coagulation in the haemato-
genous spread of cancer was first suggested
by the microcinematographic studies of
Wood (1958) using the Hopkins rabbit
ear chamber. In 1968, Gasic, Gasic and
Stewart demonstratedthatneuraminidase-
induced thrombocytopenia was associated
with a reduction of metastases from
blood-borne cancer cells. Since then,
many ultrastructural investigations have
shown platelets in close association with
haematogenous tumour cells shortly after
their arrest at the vascular endothelium
(Jones, Wallace and Fraser, 1971; Chew
and Wallace, 1976). Gasic et al. (1973,
1976) have reported that several mouse
tumours cause platelet aggregation in
vitro and that tumours with this capacity
produce more metastases. However, there
is some contrary evidence which suggests
that integrity of platelet function is not
a prerequisite for metastasis formation
(Hagmar, 1970; Hilgard, Heller and
Schmidt, 1976).
These experiments do not prove that
the thrombocytopenia which occurs after
active C. parvurn is responsible for the
vaccine's antimetastatic effects. However,
it may be a contributary factor, and we
feel that this effect should be taken into
account in studies on the antimetastatic
action of this vaccine.
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